Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi , an innovative global healthcare company, and Regeneron , a ...

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...

World shares experienced a rally following China's decision to cut key interest rates in response to economic challenges ...

Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...

The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond prices followed suit. Here to explain the significance of these market moves is ...

Wall Street indices closed mixed on Monday. Moody's downgraded the U.S. credit rating due to rising debt. S&P 500 marked its ...

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...

The Dow Jones Industrial Average finished up 0.3 per cent at 42,792.07. Read more at straitstimes.com. Read more at ...

The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...

The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure ...